Skip to main content

Table 1 Description of eosinophilia (> 500/mm3) in 26 critically ill patients with SARS-CoV-2 pneumonia

From: Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study

 

Patients with eosinophilia during ICU stay N = 26

Eosinophil count at ICU admission

 Median eosinophils count (cell/mm3)

5 [0–20]

 Eosinophilia (> 500/mm3)

1 (4)

 Eosinopenia (< 40/mm3)

22 (85)

 No eosinophil

13 (50)

 Normal eosinophil count

3 (11)

Eosinophilia during ICU stay

 Days between ICU admission and eosinophilia

19 [13–28]

 Days between disease onset and eosinophilia

30 [23–38]

 Days between disease onset and pic of eosinophilia

31 [25–42]

 Median eosinophil count (cells/mm3)

900 [678–1350]

 Severe eosinophilia (> 1500/mm3)

6 (23)

 Total duration of eosinophilia (days)

5 [3–12]

 Biphasic eosinophilia

7 (27)

 Administration of β-lactam antibiotics during eosinophilia period

10 (38)

 Temperature > 38.3 °C at least once during eosinophilia period

11 (42)

 Erythematous skin rash during the eosinophilia period

2 (8)

 Treatment with ivermectin for eosinophilia

3 (12)

  1. Continuous variables are reported as median [Interquartile range] and categorical variables are reported as numbers (percentage)